Triple Antiviral Combo Speeds COVID-19 Recovery Triple Antiviral Combo Speeds COVID-19 Recovery
The combination of lopinavir/ritonavir and ribavirin shortened median time to COVID-19 viral negativity by 5 days, according to results of an open-label, randomized phase 2 trial out of Hong Kong.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
More News: COVID-19 | Drugs & Pharmacology | Hong Kong Health | Infectious Diseases | Kaletra | Norvir